Introduction {#sec1-1}
============

The introduction of topical corticosteroids (TCs) by Sulzberger and Witten in 1952 is considered a landmark in the treatment therapy in dermatology.\[[@ref1]\] TCs are potent anti-inflammatory medications and provide symptomatic relief in many dermatological conditions. Apart from this anti-inflammatory property, they possess additional clinically valuable properties like antipruritic, immunosuppressive, and melanopenic, etc.\[[@ref2]\] These are available in the form of creams, ointments, gels, solutions, and various other vehicles. However, this effective drug has been frequently abused by ignorant users. This irrational use is promoted by the tendency of self-medication and further amplified by promotion of such products by many people notably chemists.

These topical corticosteroids are frequently used over face by people especially women for the want of a fairer skin. The face bears the brunt of this unscientific and potentially dangerous therapy as the skin is relatively thinner and more sensitive over face. The most common facial dermatoses due to topical corticosteroid abuse include steroid acne, rosacea, acneiform eruptions, hypertrichosis, and demodicosis.\[[@ref3]\] Another peculiar yet significant adverse effect noted on face which has been described by different authors include dermatitis rosaceiformis steroidica,\[[@ref4]\] steroid addiction,\[[@ref5]\] and rosacea-like dermatitis.\[[@ref6]\] The subject of TC misuse has been studied and reported around the world including Asia.\[[@ref7][@ref8][@ref9]\] However, similar data are lacking from our state and hence we undertook this study to assess the clinical presentations and associated factors with misuse of TC.

Materials and Methods {#sec1-2}
=====================

This cross-sectional study was conducted at dermatology department of a tertiary health care teaching hospital located in eastern India. The study period was for 1 year, i.e., from 1^st^ January 2018 to 31^st^ December 2018. As per the inclusion criteria for the study, we enrolled all consecutive patients of both sexes presenting with facial dermatoses who had positive history of over the counter topical corticosteroid application. The exclusion criteria included patients unwilling to voluntarily participate in the study, patients not allowing photography for clinical documentation, and patients having any comorbidities which might cause similar changes such as Cushing syndrome/thyroid disorders, etc. The continuous data were summarized as mean ± standard deviation. Comparison of these data was done by Mann\--Whitney U test. The categorical data were expressed as proportion and compared using Chi-square (χ^2^) test. A *P* \< 0.05 was considered to be statistically significant.

Results {#sec1-3}
=======

A total of 316 patients reported using topical corticosteroids on their face during the study period. Females were the overwhelming majority (83.22%) in the study participants. The mean age of female patients was 25.6 ± 2 years, whereas male patients of our cohort had a mean age of 23.8 ± 1.8 years (*P* \< 0.001). To study the epidemiological profile of the study subjects, we divided the entire population into different age groups. It was seen that majority of topicalsteroid abusers were in 20-30 years age group followed by \<20 years age group. Majority of patients were from rural areas (68.7%) among the entire cohort. To ascertain the source of the information regarding use of topical corticosteroids, we requested each subject regarding how they came to know and use these products. An overwhelming proportion was advised by their relatives/friends (57.9%), followed by pharmacists (17.7%), television andnewspaper commercials (16.1%), and doctors (8.3%), respectively. The average duration of use of such agents was around 6 ± 2 months prior to presenting to us. An interesting observation which emerged is that women tended to use these products for a longer duration of time than males prior to presentation (*P* \< 0.001). Enquiry regarding the indication for which topical corticosteroids were started revealed that majority used it for getting a "fairer skin tone" (70.6%, *n* = 223). Treatment for "cure of acne" represented the next most common reason for topical corticosteroid abuse (12.9%). The next reason of TC abuse was to treat postacne hyperpigmentation (8.8%) followed by their use as treatment for tinea and other facial dermatitides (7.7%), respectively.

When we analyzed the most common adverse reactions to these agents among study participants, it was found that new onset acne or exacerbation of preexisting acne (45.2%) represented the single most important adverse event. This was followed by erythema/telangiectasia (21.2%), pigmentation \[hyper/hypo\] (13.9%), acneiform eruptions (9.1%), hypertrichosis (6.6%), rosacea (2.2%), and atrophic scars (1.5%), respectively. Steroid-induced photosensitivity was seen in 26% of total participants. The clinical manifestations of topical steroid damaged face are summarized in Figures [1a](#F1){ref-type="fig"}-[d](#F1){ref-type="fig"}.

![(a). Severe exaggeration of acne with nodular lesions and crusting. (b). Marked erythema and telangiectasia over face. (c). Steroid-induced rosacea. (d). Steroid- induced atrophy](IDOJ-11-208-g001){#F1}

To ascertain the most common used steroid by patients, we made a detailed enquiry and reviewed all the preparations used by patients. The most common topical corticosteroid abused by our patients included mometasone valerate (40.3%) and betamethasone furoate (21.1%). Less commonly used preparations included clobetasol propronate (10.4%), beclomethasone (9.1%), fluticasone propronate (7.2%), fluocinolone acetonide (6.6%), and certain other forms.

When we compared clinicodemographic parameters among our study participants stratified by sex, we found that women tended to use TC for a longer duration of time prior to presentation as compared to their male counterparts (*P* \< 0.001). Similarly, women (63.8%) reported using TC more regularly than males (37.7%). Comparing the reason/indication for starting TC use we found that majority of males predominantly used TC as a modality for treating acne whereas females abused these agents in pursuit of getting a fairer skin. A comparative data analysis between males and females patients is presented in \[[Table 1](#T1){ref-type="table"}\]. The summary of important clinical outcomes of our study as well as of previously reported studies involving TC damaged face patients is summarized in [Table 2](#T2){ref-type="table"}.

###### 

A comparative data analysis of various parameters between male and female patients

  Serial no.   Parameters                                    Males *n*=53   Females *n*=263   *P*
  ------------ --------------------------------------------- -------------- ----------------- ---------
  1\.          Age (years)                                   23.8±1.8       25.6±2            \<0.001
  2\.          Duration of steroid use (months)              6±2            8±1.5             \<0.001
  3\.          Percentage of subjects using regularly        37.7% (20)     63.8% (168)       \<0.001
  4\.          Percentage of subjects using intermittently   62.3% (33)     36.2%(95)         \<0.001
  5\.          Indication for use                                                             
  a\.           Fairer skin                                  30.2% (16)     92.8% (207)       \<0.001
  b\.           Pigmentation (hyper/hypo)                    4.9% (2)       10.1% (26)        \<0.19
  c\.           Treatment for acne                           33.8% (18)     8.9% (23)         \<0.001
  6\.          Most common adverse effects                                                    
  a\.           Acne                                         52.8% (28)     43.7% (115)       0.23
  b\.           Erythema/telangiectasia                      54.7% (29)     14.4% (38)        \<0.001
  c\.           Hypertrichosis                               5.6% (3)       6.8% (18)         1
  d\.           Photosensitivity                             54.7% (29)     20.1% (53)        \<0.001

###### 

Comparison of important findings of various published studies with current study

  Parameters                   Present study       AI-Dhalimi and Aljawahiri\[[@ref8]\]   Saraswat *et al*.\[[@ref10]\]                 Nyati *et al*.\[[@ref11]\]   Ambika *et al*.\[[@ref12]\]   Dey *et al*.\[[@ref13]\]           Inakanti *et al*.\[[@ref14]\]      Pal *et al*.\[[@ref15]\]
  ---------------------------- ------------------- -------------------------------------- --------------------------------------------- ---------------------------- ----------------------------- ---------------------------------- ---------------------------------- --------------------------
  Duration                     1 year              1 year                                 4 months                                      1 year                       1 year                        1 year                             2 years                            6 months
  Total patients               316                 140                                    433                                           670                          200                           379                                130                                271
  Gender distribution (F:M)    263:53              95:45                                  321:112                                       487:183                      142:58                        299:80                             90:40                              197:74
  Most common age group        20-30 year          10-19 year                             \-                                            21-30 year                   15-30 year                    10-29 year                         21-30 year                         20-29 year
  Most common indication       Skin lightening     Skin lightening                        Face cream/fairness cream/after shave cream   Acne                         Acne                          Skin lightening                    Fairness creams                    Acne
  Most common source of use    Friends/relatives   Paramedical personnel                  Friend/peer/relative                          Pharmacist (OTC)             Friend/peer/relative          Pharmacist/Paramedical personnel   Registered medical practitioners   Pharmacist
  Most common side effect      Acne                Acne                                   Acne                                          Acneiform eruption           Acneiform eruption            Acne                               Acneiform eruptions                Rosacea/photosensitivity
  Most common steroid abused   Mometasone          Clobetasol                             Betamethasone                                 Betamethasone                Betamethasone                 Mixed (potent and very potent)     Betamethasone                      Mid potent

Discussion {#sec1-4}
==========

The ever-increasing fantasy of getting a fairer skin tone in a dark-skinned country like ours pushes people to use every product which promises to do so without consulting a specialist. The problem is worsened when these products are endorsed by various film and television celebrities who are idolized in a country like ours. Topical steroid damaged/dependent face is a problem faced all over the world.\[[@ref5][@ref7][@ref8][@ref9]\] In India, the problem is even bigger because all these products are easily available without prescription. A multicenter study was conducted in various parts of India and compiled to form a larger study by Saraswat *et al*.\[[@ref10]\] and has been published earlier.

We found that about 7% of the patients visiting our outpatient department had been misusing/abusing topical steroids over face which issimilar to results reported by authors from Iraq\[[@ref8]\] who reported around 7.9% of subjects presenting with similar problems in their region. In contrast to it, Saraswat *et al*. had reported albeit a higher (15%) figure from their study regarding prevalence of TC abused face.\[[@ref10]\] Most of the patients in our study belonged to age group 20\--30 years which has been similarly reported in various other studies depicting the vulnerability of this age group.\[[@ref10][@ref11][@ref12][@ref15]\] In agreement to previous published studies, we also saw that acne and flare of pre-existing acne post topical steroid misuse/abuse was the most common reported adverse event.\[[@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref16]\]

Most common TC abused as reported in the previous studieswere superpotent formulations,\[[@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14]\] while mid potent formulation (mometasone) was the most common abused TC in our study, which is similar to Pal *et al*.\[[@ref15]\] The reason could be attributed to ever-increasing popularity of triple combination (mometasone, hydroquinone, and tretinoin) for fairness creams leading to a plethora of products with this formulation in the Indian market. The most common stimulus for the patients in our study to use these products was suggestions from close friends and relative sin congruent to previous reports.\[[@ref10]\] An important point which our study highlights is that 16.1% of subjects used topical steroids after seeing television/newspaper commercials. This helps us understand the amount of effect which such unscrupulous advertisement by various pharmaceutical companies has on life, health, and mind of people. The ignorant patients go on using the products even after getting the side-effects with hope of improvement in skin color but instead it worsens the scenario. The only and most effective treatment in such patients is the complete stoppage of these topical applications along with the symptomatic treatment.\[[@ref3]\] The various medications used are tetracycline, isotretinoin, antihistaminics, and moisturizers with strict photoprotection.

Conclusion {#sec1-5}
==========

The unchecked use of topical steroids is an ever-increasing problem in our country. The reasons are many as are found in our study. Our study highlights the magnitude and demographics of TC abuse facial dermatoses in our community and cover the various clinical phenotypes associated with it. To solve the problem of TC abuse, stringent laws are required to put a check on various pharmaceutical companies promoting honey-coated television commercials which blinds the user about the various side-effects of such formulations. The problem is perpetuated by the unrealistic craze and want of fairer skin by our people coupled with easy access to such products as cheap over the counter products.
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